Daily News Podcast

Antibody cleared amyloid plaques, slowed cognitive decline


 

An experimental agent slowed cognitive decline and cleared Alzheimer’s plaques. Can meteorology predict migraines? Why closing a patent foramen ovale is the right approach to prevent recurring ischemic stroke. And claims that cannabis relieves noncancer pain go up in smoke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Hematology and Oncology
MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Hematology and Oncology
MDedge Daily News: Do HPV vaccines really cut cancer risk?
MDedge Hematology and Oncology
NIH launches HEAL Initiative to combat opioid crisis
MDedge Hematology and Oncology
Do free meals to physicians affect opioid prescribing?
MDedge Hematology and Oncology
Fentanyl analogs nearly double their overdose death toll
MDedge Hematology and Oncology
Is fibromyalgia one disorder – or two?
MDedge Hematology and Oncology
Is fish oil’s heart benefit a fish tale?
MDedge Hematology and Oncology
Guideline: PFO closure best bet for recurrent stroke prevention
MDedge Hematology and Oncology
Blood pressure meds cut cognitive impairment risk
MDedge Hematology and Oncology